Roberto Roberto Lara-Lemus

Dr. Roberto Roberto Lara-Lemus

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2009 in Diabetes
Verified
Journal Article
Open access
PDF file
TNTamara J. Nicolson
Tamara J. Nicolson
EBElisa A. Bellomo
Elisa A. Bellomo
NWNadeeja Wijesekara
Nadeeja Wijesekara
MLMerewyn K. Loder
Merewyn K. Loder
JBJocelyn M. Baldwin
Jocelyn M. Baldwin
GRGuy A. Rutter
Guy A. Rutter
OBJECTIVE Zinc ions are essential for the formation of hexameric insulin and hormone crystallization. A nonsynonymous single nucleotide polymorphism rs13266634 in the SLC30A8 gene, encoding the secretory granule zinc transporter ZnT8, is associated with type 2 diabetes. We describe the effects of deleting the ZnT8 gene in mice and explore the action of the at-risk allele. RESEARCH DESIGN AND METHODS Slc30a8 null mice were generated and backcrossed at least twice onto a C57BL/6J background. Glucose and insulin tolerance were measured by intraperitoneal injection or euglycemic clamp, respectively. Insulin secretion, electrophysiology, imaging, and the generation of adenoviruses encoding the low- (W325) or elevated- (R325) risk ZnT8 alleles were undertaken using standard protocols. RESULTS ZnT8−/− mice displayed age-, sex-, and diet-dependent abnormalities in glucose tolerance, insulin secretion, and body weight. Islets isolated from null mice had reduced granule zinc content and showed age-dependent changes in granule morphology, with markedly fewer dense cores but more rod-like crystals. Glucose-stimulated insulin secretion, granule fusion, and insulin crystal dissolution, assessed by total internal reflection fluorescence microscopy, were unchanged or enhanced in ZnT8−/− islets. Insulin processing was normal. Molecular modeling revealed that residue-325 was located at the interface between ZnT8 monomers. Correspondingly, the R325 variant displayed lower apparent Zn2+ transport activity than W325 ZnT8 by fluorescence-based assay. CONCLUSIONS ZnT8 is required for normal insulin crystallization and insulin release in vivo but not, remarkably, in vitro. Defects in the former processes in carriers of the R allele may increase type 2 diabetes risks.

1 November 2010 in Trends in Endocrinology & Metabolism
Verified
Journal Article
Closed access
MLMing Liu
Ming Liu
IHIsrael Hodish
Israel Hodish
LHLeena Haataja
Leena Haataja
RLRoberto Roberto Lara-Lemus
Roberto Roberto Lara-Lemus
GRGautam Rajpal
Gautam Rajpal
PAPeter Arvan
Peter Arvan

14 March 2012 in Diabetes
Verified
Journal Article
Open access
PDF file
MLMing Liu
Ming Liu
RLRoberto Roberto Lara-Lemus
Roberto Roberto Lara-Lemus
SSShu-Ou Shan
Shu-Ou Shan
JWJordan Wright
Jordan Wright
LHLeena Haataja
Leena Haataja
PAPeter Arvan
Peter Arvan
Recently, missense mutations upstream of preproinsulin’s signal peptide (SP) cleavage site were reported to cause mutant INS gene-induced diabetes of youth (MIDY). Our objective was to understand the molecular pathogenesis using metabolic labeling and assays of proinsulin export and insulin and C-peptide production to examine the earliest events of insulin biosynthesis, highlighting molecular mechanisms underlying β-cell failure plus a novel strategy that might ameliorate the MIDY syndrome. We find that whereas preproinsulin-A(SP23)S is efficiently cleaved, producing authentic proinsulin and insulin, preproinsulin-A(SP24)D is inefficiently cleaved at an improper site, producing two subpopulations of molecules. Both show impaired oxidative folding and are retained in the endoplasmic reticulum (ER). Preproinsulin-A(SP24)D also blocks ER exit of coexpressed wild-type proinsulin, accounting for its dominant-negative behavior. Upon increased expression of ER–oxidoreductin-1, preproinsulin-A(SP24)D remains blocked but oxidative folding of wild-type proinsulin improves, accelerating its ER export and increasing wild-type insulin production. We conclude that the efficiency of SP cleavage is linked to the oxidation of (pre)proinsulin. In turn, impaired (pre)proinsulin oxidation affects ER export of the mutant as well as that of coexpressed wild-type proinsulin. Improving oxidative folding of wild-type proinsulin may provide a feasible way to rescue insulin production in patients with MIDY.

1 April 2000 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
JSJesus Silva-Sanchez
Jesus Silva-Sanchez
CAC. Aguilar
C. Aguilar
GAG. Ayala
G. Ayala
MEM. A. Estrada
M. A. Estrada
UGU. Garza-Ramos
U. Garza-Ramos
LLL. Ledezma
L. Ledezma
Escherichia coli R170, isolated from the urine of an infected patient, was resistant to expanded-spectrum cephalosporins, aztreonam, ciprofloxacin, and ofloxacin but was susceptible to amikacin, cefotetan, and imipenem. This particular strain contained three different plasmids that encoded two β-lactamases with pIs of 7.0 and 9.0. Resistance to cefotaxime, ceftazidime, aztreonam, trimethoprim, and sulfamethoxazole was transferred by conjugation from E. coli R170 to E. coli J53-2. The transferred plasmid, RZA92, which encoded a single β-lactamase, was 150 kb in length. The cefotaxime resistance gene that encodes the TLA-1 β-lactamase (pI 9.0) was cloned from the transconjugant by transformation to E. coli DH5α. Sequencing of the bla TLA-1 gene revealed an open reading frame of 906 bp, which corresponded to 301 amino acid residues, including motifs common to class A β-lactamases: 70 SXXK, 130 SDN, and 234 KTG. The amino acid sequence of TLA-1 shared 50% identity with the CME-1 chromosomal class A β-lactamase from Chryseobacterium ( Flavobacterium ) meningosepticum ; 48.8% identity with the VEB-1 class A β-lactamase from E. coli ; 40 to 42% identity with CblA of Bacteroides uniformis , PER-1 of Pseudomonas aeruginosa , and PER-2 of Salmonella typhimurium ; and 39% identity with CepA of Bacteroides fragilis . The partially purified TLA-1 β-lactamase had a molecular mass of 31.4 kDa and a pI of 9.0 and preferentially hydrolyzed cephaloridine, cefotaxime, cephalothin, benzylpenicillin, and ceftazidime. The enzyme was markedly inhibited by sulbactam, tazobactam, and clavulanic acid. TLA-1 is a new extended-spectrum β-lactamase of Ambler class A.

1 June 2008 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
YYYukihiro Yamaguchi
Yukihiro Yamaguchi
DLDennis Larkin
Dennis Larkin
RLRoberto Roberto Lara-Lemus
Roberto Roberto Lara-Lemus
JRJose Ramos-Castañeda
Jose Ramos-Castañeda
MLMing Liu
Ming Liu
PAPeter Arvan
Peter Arvan
The activity of PERK, an endoplasmic reticulum (ER) transmembrane protein kinase, assists in an ER stress response designed to inhibit general protein synthesis while allowing upregulated synthesis of selective proteins such as the ATF4 transcription factor. PERK null mice exhibit phenotypes that especially affect secretory cell types. Although embryonic fibroblasts from these mice are difficult to transfect with high efficiency, we have generated 293 cells stably expressing the PERK-K618A dominant negative mutant. 293/PERK-K618A cells, in response to ER stress: (a) do not properly inhibit general protein synthesis, (b) exhibit defective/delayed induction of ATF4 and BiP, and (c) exhibit exuberant splice activation of XBP1 and robust cleavage activation of ATF6, with abnormal regulation of calreticulin levels. The data suggest compensatory mechanisms allowing for cell survival in the absence of functional PERK. Interestingly, although induction of CHOP (a transcription factor implicated in apoptosis) is notably delayed after onset of ER stress, 293/PERK-K618A cells eventually produce CHOP at normal or even supranormal levels and exhibit increased apoptosis either in response to general ER stress or, more importantly, to specific misfolded secretory proteins.

1 September 1992 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
RLRoberto Roberto Lara-Lemus
Roberto Roberto Lara-Lemus
CLCarlos A. Libreros-Minotta
Carlos A. Libreros-Minotta
MAMyriam M. Altamirano
Myriam M. Altamirano
MCMario L. Calcagno
Mario L. Calcagno